Saving & Investing

Merck Quarterly Profit Beats Analysts’ Estimates

Merck CEO Seeks Drug Add-Ons, Not Large Tax-Inversion Deals

Merck & Co., the second-biggest U.S. drugmaker, is staying in the U.S. and sticking to a bolt-on acquisition strategy, shunning the route taken by its... Read More »

Advertisements
Advertisement

Key Rates

Mortgage
  • Mortgage
  • Home Equity
  • Savings
  • Auto
  • Credit Cards
Advertisement
Sponsored Links